Clinical Trials Browser

Phase 3 × INDUSTRY × nelarabine × Clear all

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Phase 3 Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma